QBIO

Q BioMed Inc

QBIO · OTC · Health Technology, Pharmaceuticals Major · Founded 2013

Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01.

Current Price
—
Market Cap
—
Return Since Last Split
—
Last Split
Aug 7, 2015
Total Splits
1
Cumulative Multiple
2×

What If You Bought QBIO Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
200 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Aug 7, 2015—2-for-12×2×

Q BioMed Inc Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Q BioMed Inc's latest record in the split calendar is a 2-for-1 forward split effective 2015-08-07.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.